May 21, 2026 06:36AM

May 5, 2026 04:34PM

Apr 2, 2026 12:00PM

Apr 2, 2026 10:46AM

Apr 2, 2026 08:31AM

Mar 30, 2026 08:32AM

Mar 24, 2026 02:32AM Goldman Sachs Downgrades Ultragenyx Pharma (RARE) to Neutral

Mar 12, 2026 11:55AM

Mar 12, 2026 11:55AM

Mar 12, 2026 10:39AM

Feb 18, 2026 06:44AM

Feb 12, 2026 04:30PM

Feb 3, 2026 06:44AM

Jan 30, 2026 08:31AM Ultragenyx resubmits gene therapy application for rare brain disease

Jan 12, 2026 07:31AM

Jan 6, 2026 06:42AM

Jan 5, 2026 07:35AM

Jan 2, 2026 05:25AM

Dec 31, 2025 09:23AM

Dec 30, 2025 04:06PM

Dec 30, 2025 04:58AM Ultragenyx Pharma (RARE) PT Lowered to $45 at Wells Fargo

Dec 30, 2025 04:55AM

Dec 30, 2025 04:54AM

Dec 30, 2025 02:03AM

Dec 29, 2025 03:27PM

Dec 29, 2025 03:27PM

Dec 29, 2025 01:50PM

Dec 29, 2025 01:11PM LifeSci Capital Downgrades Mereo BipPharma Group (MREO) to Market Perform

Dec 29, 2025 12:48PM

Dec 29, 2025 12:12PM

Dec 29, 2025 12:04PM

Dec 29, 2025 12:04PM

Dec 29, 2025 12:03PM

Dec 29, 2025 12:03PM

Dec 29, 2025 08:25AM Ultragenyx Pharma (RARE) halted, news pending

Nov 21, 2025 07:13AM

Nov 5, 2025 09:34AM

Nov 5, 2025 04:51AM

Nov 4, 2025 04:19PM

Oct 17, 2025 05:56AM

Sep 22, 2025 07:15AM

Sep 9, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)

Aug 18, 2025 08:06AM

Jul 28, 2025 06:58AM

Jul 14, 2025 08:01AM

Jul 14, 2025 05:08AM

Jul 11, 2025 05:05PM

Jul 11, 2025 04:30PM

Jul 10, 2025 10:52AM TD Cowen: 'Ultragenyx Pharma (RARE) a Buying Oppy Ahead Of Dec '25 Readout'

Jul 10, 2025 07:49AM

416,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All